DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma

NCT00889408 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma

Interventions

BIOLOGICAL: DT2219ARL

Sponsor

Masonic Cancer Center, University of Minnesota

Collaborators

[object Object]